指南与共识复苏、休克与脓毒症重症综合管理与镇静镇痛

2023年拯救脓毒症运动研究优先方向

Surviving Sepsis Campaign Research Priorities 2023.
PubMed 文献 · Crit Care Med · 2024-01-19
一句话结论拯救脓毒症运动研究委员会提出2023年脓毒症研究优先方向,包括5个临床和5个基础科学优先问题。

拯救脓毒症研究委员会由代表欧洲重症医学会和美国重症医学会的16名国际专家组成,在最新版拯救脓毒症运动指南发布后不久,通过线上会议和迭代方式制定本文。委员会成员提交脓毒症相关研究问题,经合并后共有34个临床和10个基础科学问题提交投票,最终确定临床和基础科学各5个最高优先问题。临床优先问题涵盖脓毒症筛查与识别、器官损伤定义与检测、液体复苏个体化、不同阶段脓毒性休克血管加压药策略以及精准医学识别最佳治疗。基础科学优先问题涵盖动物模型改进、结局变量选择、脓毒症对大脑及神经内分泌免疫交互的影响、微生物组和遗传表观遗传学。作者指出现有证据强度有限、知识缺口显著、脓毒症死亡率仍高,这些优先方向为脓毒症和脓毒性休克研究提供路线图。

要点

  • 临床优先方向1:脓毒症筛查和识别的最佳策略是什么,预测模型能否辅助实时识别脓毒症
  • 临床优先方向2:脓毒症器官损伤和功能障碍的原因是什么,应如何定义和检测
  • 临床优先方向3:初始及后续液体复苏应如何个体化
  • 临床优先方向4:治疗不同阶段脓毒性休克的最佳血管加压药策略是什么
  • 临床优先方向5:个性化/精准医学方法能否识别改善患者结局的最佳治疗

研究设计与关键结果

  • 研究类型:拯救脓毒症运动研究委员会更新文章,由代表欧洲重症医学会和美国重症医学会的16名国际专家通过线上会议和迭代方式制定,更新自2018年拯救脓毒症运动研究优先方向。
  • 方法:每名工作组成员提交5个脓毒症相关研究问题,委员会成员独立对生成列表中的前三个优先事项进行排名;共提交81个问题,合并相似问题后,34个临床和10个基础科学研究问题提交投票。
  • 临床前5位优先问题:1)脓毒症筛查和识别的最佳策略是什么,预测模型能否辅助实时识别脓毒症;2)脓毒症器官损伤和功能障碍的原因是什么,应如何定义和检测;3)初始及后续液体复苏应如何个体化;4)治疗不同阶段脓毒性休克的最佳血管加压药策略是什么;5)个性化/精准医学方法能否识别改善患者结局的最佳治疗。
  • 基础科学前5位优先问题:1)如何改进动物模型使其更接近人类脓毒症;2)哪些结局变量能最大化人类脓毒症与动物模型之间的相关性并因此最适合两者使用;3)脓毒症如何影响大脑,脓毒症所致大脑改变如何导致器官功能障碍,脓毒症如何影响神经、内分泌和免疫系统之间的相互作用;4)微生物组如何影响脓毒症病理生物学;5)遗传学和表观遗传学如何影响脓毒症的发生、病程及对治疗的反应。

证据类型、等级与局限

  • 证据类型:拯救脓毒症运动研究委员会专家共识更新文章。
  • 局限:现有证据强度有限,存在显著知识缺口,脓毒症死亡率仍高。

指南或共识出处

  • Surviving Sepsis Campaign Research Priorities 2023,发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To identify research priorities in the management, epidemiology, outcome, and pathophysiology of sepsis and septic shock.

DESIGN: Shortly after publication of the most recent Surviving Sepsis Campaign Guidelines, the Surviving Sepsis Research Committee, a multiprofessional group of 16 international experts representing the European Society of Intensive Care Medicine and the Society of Critical Care Medicine, convened virtually and iteratively developed the article and recommendations, which represents an update from the 2018 Surviving Sepsis Campaign Research Priorities.

METHODS: Each task force member submitted five research questions on any sepsis-related subject. Committee members then independently ranked their top three priorities from the list generated. The highest rated clinical and basic science questions were developed into the current article.

RESULTS: A total of 81 questions were submitted. After merging similar questions, there were 34 clinical and ten basic science research questions submitted for voting. The five top clinical priorities were as follows: 1) what is the best strategy for screening and identification of patients with sepsis, and can predictive modeling assist in real-time recognition of sepsis? 2) what causes organ injury and dysfunction in sepsis, how should it be defined, and how can it be detected? 3) how should fluid resuscitation be individualized initially and beyond? 4) what is the best vasopressor approach for treating the different phases of septic shock? and 5) can a personalized/precision medicine approach identify optimal therapies to improve patient outcomes? The five top basic science priorities were as follows: 1) How can we improve animal models so that they more closely resemble sepsis in humans? 2) What outcome variables maximize correlations between human sepsis and animal models and are therefore most appropriate to use in both? 3) How does sepsis affect the brain, and how do sepsis-induced brain alterations contribute to organ dysfunction? How does sepsis affect interactions between neural, endocrine, and immune systems? 4) How does the microbiome affect sepsis pathobiology? 5) How do genetics and epigenetics influence the development of sepsis, the course of sepsis and the response to treatments for sepsis?

CONCLUSIONS: Knowledge advances in multiple clinical domains have been incorporated in progressive iterations of the Surviving Sepsis Campaign guidelines, allowing for evidence-based recommendations for short- and long-term management of sepsis. However, the strength of existing evidence is modest with significant knowledge gaps and mortality from sepsis remains high. The priorities identified represent a roadmap for research in sepsis and septic shock.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. De Backer D, Deutschman CS, Hellman J, et al. Surviving Sepsis Campaign Research Priorities 2023. Crit Care Med. 2024. PMID: 38240508. doi:10.1097/CCM.0000000000006135

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。